Basic design considerations for clinical trials in oncology.

Design considerations for nanotherapeutics in oncology.

Design considerations for AIDS trials.

Study design considerations for irritable bowel syndrome clinical trials.

Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology.

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia.

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.

Molecular imaging biomarkers for oncology clinical trials.

A Bayesian Dose-finding Design for Oncology Clinical Trials of Combinational Biological Agents.

Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure.

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Geriatric pharmacology: basic and clinical considerations.

A re-randomisation design for clinical trials.

Design of forms for clinical trials.

Design of forms for clinical trials (2).

Ethical considerations in phase I clinical trials.

Design of forms for clinical trials (1).

Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.

Ethical considerations for clinical trials in inflammatory bowel disease.

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.

Letter: Design of clinical trials.

Calibration of quality-adjusted life years for oncology clinical trials.

Clinical trials: impact evaluation and implementation considerations.

Letter: Design of clinical trials.

Perfusion imaging in neuro-oncology: basic techniques and clinical applications.

Suggest Documents

Design considerations for nanotherapeutics in oncology.

Design considerations for AIDS trials.

Study design considerations for irritable bowel syndrome clinical trials.

Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology.

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia.

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.

Molecular imaging biomarkers for oncology clinical trials.

A Bayesian Dose-finding Design for Oncology Clinical Trials of Combinational Biological Agents.

Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure.

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Geriatric pharmacology: basic and clinical considerations.

A re-randomisation design for clinical trials.

Design of forms for clinical trials.

Design of forms for clinical trials (2).

Ethical considerations in phase I clinical trials.

Design of forms for clinical trials (1).

Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.

Ethical considerations for clinical trials in inflammatory bowel disease.

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.

Letter: Design of clinical trials.

Calibration of quality-adjusted life years for oncology clinical trials.

Clinical trials: impact evaluation and implementation considerations.

Letter: Design of clinical trials.

Perfusion imaging in neuro-oncology: basic techniques and clinical applications.

Basic design considerations for clinical trials in oncology.

Recommend Documents

Follow Us